Early test of potential cholesterol fighter begins
NCT ID NCT06238466
Summary
This is a first-in-human study to check if a new drug called AZD1705 is safe for people with high cholesterol. Researchers will give single and repeated doses to 96 participants and closely monitor for side effects. They will also measure how the drug moves through the body and its early effects on cholesterol levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Glendale, California, 91206, United States
-
Research Site
Jacksonville, Florida, 32216, United States
-
Research Site
Winter Park, Florida, 32789, United States
-
Research Site
Baltimore, Maryland, 21225, United States
-
Research Site
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.